BB

Biswdeo Bajpayee

Active Director Whole-Time Director DIN 08824306
DIN 08824306 First appointment Aug 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Biswdeo Bajpayee

Data last updated:

Biswdeo Bajpayee is a Whole-Time Director at Myrxbharat Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals.

DIN 08824306
Primary Designation Whole-Time Director
Industry Chemicals
First Appointment 06 Aug 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director06 Aug 20202020Active

Board colleagues of Biswdeo Bajpayee

NameDINCompanyDesignation
Ankita Shashi Bhushan Tiwari08824307Myrxbharat Pharmaceuticals Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Myrxbharat Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Biswdeo Bajpayee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biswdeo Bajpayee

Biswdeo Bajpayee currently holds 1 directorship: Myrxbharat Pharmaceuticals Private Limited (Whole-Time Director, since 06 Aug 2020).

Biswdeo Bajpayee was first appointed on 06 Aug 2020 as Whole-Time Director at Myrxbharat Pharmaceuticals Private Limited.

The current boards of Biswdeo Bajpayee's companies include Ankita Shashi Bhushan Tiwari (Myrxbharat Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available